DrugPatentWatch Database Preview
Details for Patent: 8,367,649
» See Plans and Pricing
Which drugs does patent 8,367,649 protect, and when does it expire?
Patent 8,367,649 protects KYBELLA and is included in one NDA.
Summary for Patent: 8,367,649
| Title: | Formulations of deoxycholic acid and salts thereof |
| Abstract: | The present application is directed to an aqueous pharmaceutical formulation comprising less than about 5% w/v sodium deoxycholate maintained at a pH sufficient to substantially inhibit precipitation of the sodium deoxycholate. Also disclosed herein, are methods for inhibiting precipitation of sodium deoxycholate in an aqueous solution comprising less than about 5% w/v of sodium deoxycholate, said method comprising maintaining pH of the solution of from at least about 8.0 to about 8.5. |
| Inventor(s): | Hodge; Robert Emil (Thousand Oaks, CA), Webster; Jeffrey Douglas (Thousand Oaks, CA) |
| Assignee: | Kythera Biopharmaceuticals, Inc. (Calabasas, CA) |
| Application Number: | 13/323,605 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,367,649 |
|
Patent Claim Types: see list of patent claims | Composition; Formulation; |
Drugs Protected by US Patent 8,367,649
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kythera Biopharms | KYBELLA | deoxycholic acid | SOLUTION;SUBCUTANEOUS | 206333-001 | Apr 29, 2015 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
